As of 2026-06-24, the Fair Value of Regulus Therapeutics Inc (RGLS) is -3.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.16 USD, the upside of Regulus Therapeutics Inc is -142.06%.
With the market price of 8.16 USD and our fair value calculation, Regulus Therapeutics Inc (RGLS) is not a good investment. Investing in RGLS stocks now will result in a potential loss of 142.06%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -15.73 | -27.81 | -28.32 | -30.04 | -46.36 | -29.65 |
| YoY growth | 15.39% | -76.78% | -1.85% | -6.05% | -54.34% | -24.73% |
| Market Cap (mil) | 564.92 |
| P/E | |
| Forward P/E |
| EPS | -0.69 |
| Avg earnings growth rate | -24.73% |
| TTM earnings | -47.52 |